QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 172 filers reported holding QIAGEN NV in Q4 2014. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,117,000 | +4.9% | 141,495 | -1.1% | 0.01% | -6.7% |
| Q3 2016 | $3,926,000 | +15.6% | 143,084 | -8.1% | 0.02% | +15.4% |
| Q2 2016 | $3,397,000 | +4.0% | 155,735 | +6.5% | 0.01% | 0.0% |
| Q1 2016 | $3,266,000 | -21.8% | 146,195 | -3.2% | 0.01% | -23.5% |
| Q4 2015 | $4,176,000 | +8.8% | 151,016 | +1.5% | 0.02% | +6.2% |
| Q3 2015 | $3,839,000 | +37.4% | 148,784 | +32.0% | 0.02% | +45.5% |
| Q2 2015 | $2,794,000 | +29.0% | 112,723 | +31.1% | 0.01% | +10.0% |
| Q1 2015 | $2,166,000 | +1.5% | 85,951 | -5.5% | 0.01% | +11.1% |
| Q4 2014 | $2,135,000 | +5.0% | 90,996 | +1.9% | 0.01% | +12.5% |
| Q3 2014 | $2,033,000 | -6.9% | 89,280 | 0.0% | 0.01% | -11.1% |
| Q2 2014 | $2,183,000 | +12.8% | 89,280 | -2.7% | 0.01% | 0.0% |
| Q1 2014 | $1,935,000 | +14.8% | 91,767 | +29.6% | 0.01% | +28.6% |
| Q4 2013 | $1,686,000 | – | 70,825 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
| Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
| Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
| Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
| Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
| Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
| Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |